Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Kennedy B Nkhoma, Lindsay Farrant, Olona Mzimkulu, Joy Hunter, Irene Higginson, Wei Gao, Matthew Maddocks, Liz Gwyther & Richard Harding. (2023) High Prevalence and Burden of Physical and Psychological Symptoms in a Chronic Obstructive Pulmonary Disease Population in Primary Care Settings in South Africa. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1665-1679.
Read now
Read now
Clarus Leung & Don D. Sin. (2022) Pharmacotherapy considerations for morning symptoms in chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 23:12, pages 1359-1362.
Read now
Read now
Tian Sun, Xiaoyun Li, Wei Cheng, Yating Peng, Yiyang Zhao, Cong Liu, Yuqin Zeng, Yan Chen, Shan Cai & Ping Chen. (2020) The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1899-1907.
Read now
Read now
Line Hust Storgaard, Ulla Møller Weinreich & Birgitte Schantz Laursen. (2020) COPD Patients’ Experience of Long-Term Domestic Oxygen-Enriched Nasal High Flow Treatment: A Qualitative Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:2, pages 175-183.
Read now
Read now
Ioanna Tsiligianni, Maria Kampouraki, Despo Ierodiakonou, Ioannis Poulonirakis & Polyvios Papadokostakis. (2019) COPD patients’ characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 547-556.
Read now
Read now
Marco Basile, Pierpaolo Baiamonte, Emilia Mazzuca, Stefania Principe, Federica Pennavaria, Alida Benfante & Nicola Scichilone. (2018) Sleep Disturbances in COPD are Associated with Heterogeneity of Airway Obstruction. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:4, pages 350-354.
Read now
Read now
Kate M Johnson, Abdollah Safari, Wan C Tan, Jean Bourbeau, J Mark FitzGerald, Mohsen Sadatsafavi & On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD) study. (2018) Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3983-3995.
Read now
Read now
Cecilia Calabrese, Adriano Costigliola, Marianna Maffei, Vittorio Simeon, Francesco Perna, Eugenio Tremante, Elena Merola, Carlo Antonio Leone & Andrea Bianco. (2018) Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2025-2032.
Read now
Read now
Anna Muñoz, Mark Small, Robert Wood, Anna Ribera & Javier Nuevo. (2018) The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1557-1568.
Read now
Read now
Amnon Ariel, Alan Altraja, Andrey Belevskiy, Piotr W Boros, Edvardas Danila, Matjaz Fležar, Vladimir Koblizek, Zvi G Fridlender, Kosta Kostov, Alvils Krams, Branislava Milenkovic, Attila Somfay, Ruzena Tkacova, Neven Tudoric, Ruxandra Ulmeanu & Arschang Valipour. (2018) Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 45-56.
Read now
Read now
Johannes Krönig, Olaf Hildebrandt, Andreas Weissflog, Werner Cassel, Volker Gross, Keywan Sohrabi, Patrick Fischer & Ulrich Koehler. (2017) Long-term Recording of Night-Time Respiratory Symptoms in Patients with Stable COPD II–IV. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:5, pages 498-503.
Read now
Read now
Amanda R van Buul, Marise J Kasteleyn, Niels H Chavannes & Christian Taube. (2017) The association between objectively measured physical activity and morning symptoms in COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2831-2840.
Read now
Read now
Bo Ding, Mark Small & Ulf Holmgren. (2017) A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1527-1537.
Read now
Read now
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2017) Morning symptoms in COPD: a treatable yet often overlooked factor. Expert Review of Respiratory Medicine 11:4, pages 311-322.
Read now
Read now
Marc Miravitlles, Heinrich Worth, Juan José Soler-Cataluña, David Price, Fernando De Benedetto, Nicolas Roche, Nina S. Godtfredsen, Thys van der Molen, Claes-Göran Löfdahl, Laura Padullés & Anna Ribera. (2016) The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS). COPD: Journal of Chronic Obstructive Pulmonary Disease 13:5, pages 561-568.
Read now
Read now
Maria Gabriella Matera, Alessandro Sanduzzi & Mario Cazzola. (2016) Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 73-79.
Read now
Read now
Judith J Stephenson, Qian Cai, Michelle Mocarski, Hiangkiat Tan, Jalpa A Doshi & Sean D Sullivan. (2015) Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 577-586.
Read now
Read now
Chen Wang, Tieying Sun, Yijiang Huang, Michael Humphries, Lingyan Bai, Lilly Li, Qian Wang, Pearl Kho, Roz Firth & Peter D’Andrea. (2015) Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 57-68.
Read now
Read now
Articles from other publishers (27)
O. N. Titova, N. A. Kuzubova, A. G. Kozyrev & A. A. Shumilov. (2023) Bronchodilator therapy in patients with chronic obstructive pulmonary disease: what should be considered in clinical practice when choosing a dosing regimen?. PULMONOLOGIYA 33:1, pages 44-50.
Crossref
Crossref
Fang Liu & Demosthenes Panagiotakos. (2022) Real-world data: a brief review of the methods, applications, challenges and opportunities. BMC Medical Research Methodology 22:1.
Crossref
Crossref
Leif H. Bjermer, Isabelle H. Boucot, Claus F. Vogelmeier, François Maltais, Paul W. Jones, Lee Tombs, Chris Compton, David A. Lipson & Edward M. Kerwin. (2021) Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial. Advances in Therapy 38:9, pages 4815-4835.
Crossref
Crossref
Wenwen Han, Xin Peng, Danhua Qu, Yuhang Yang & Kun Li. (2020) Heavy shackles: The experience of symptom distress and coping behaviors of Chinese patients with chronic obstructive pulmonary disease. Nursing & Health Sciences 22:4, pages 1177-1185.
Crossref
Crossref
Ioanna Tsiligianni & Janwillem W. H. Kocks. (2020) Daytime symptoms of chronic obstructive pulmonary disease: a systematic review. npj Primary Care Respiratory Medicine 30:1.
Crossref
Crossref
Nafeez Syed, Jeremy D. Road, Christopher J. Ryerson & Jordan A. Guenette. (2020) Evaluation of the Vibe Actigraph in Patients With Chronic Obstructive Pulmonary Disease: A Pilot Study. IEEE Journal of Translational Engineering in Health and Medicine 8, pages 1-8.
Crossref
Crossref
Tadashi Kamei, Hiroyuki NakamuraDr.Dr., Nobuki NankiDr.Dr., Yoshiaki MinakataDr.Dr., Kazuto MatsunagaDr.Dr. & Yoshihiro MoriDr.Dr.. (2019) Clinical benefit of two-times-per-day aclidinium bromide compared with once-a-day tiotropium bromide hydrate in COPD: a multicentre, open-label, randomised study. BMJ Open 9:7, pages e024114.
Crossref
Crossref
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2018) Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms. Respiratory Research 19:1.
Crossref
Crossref
Maochun Wu, Zequan Wang, Manman Li & Kun Li. (2017) Daily Symptom Variability in Patients With Stable COPD: A Narrative Review. Western Journal of Nursing Research 40:10, pages 1543-1561.
Crossref
Crossref
Maria Comas, Christopher J. Gordon, Brian G. Oliver, Nicholas W. Stow, Gregory King, Pawan Sharma, Alaina J. Ammit, Ronald R. Grunstein & Craig L. Phillips. (2017) A circadian based inflammatory response – implications for respiratory disease and treatment. Sleep Science and Practice 1:1.
Crossref
Crossref
Marc Miravitlles & Anna Ribera. (2017) Understanding the impact of symptoms on the burden of COPD. Respiratory Research 18:1.
Crossref
Crossref
F. Blasi, G. W. Canonica & M. Miravitlles. (2017) Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?. Respiratory Research 18:1.
Crossref
Crossref
Hiroyuki Ohbayashi. (2017) Comparison of the rapid effects of single inhalations of formoterol and tiotropium bromide on respiratory function and COPD symptoms in a randomized crossover study. Respiratory Investigation 55:6, pages 348-356.
Crossref
Crossref
G.W. Canonica, F. Blasi, N. Scichilone, L. Simoni, A. Zullo, C. Giovannetti, C. Briguglio, S. Barsanti & R. Antonelli Incalzi. (2017) Characterization of circadian COPD symptoms by phenotype: Methodology of the STORICO observational study. European Journal of Internal Medicine 43, pages 62-68.
Crossref
Crossref
Marc Miravitlles, José Luis Izquierdo, Cristina Esquinas, Maite Pérez, Myriam Calle, José Luis López-Campos, José Miguel Rodríguez González-Moro, Ciro Casanova, Cristóbal Esteban & Pilar de Lucas. (2017) The variability of respiratory symptoms and associated factors in COPD. Respiratory Medicine 129, pages 165-172.
Crossref
Crossref
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2017) Association between morning symptoms and physical activity in COPD: a systematic review. European Respiratory Review 26:143, pages 160033.
Crossref
Crossref
Dave Singh, Marc Miravitlles & Claus Vogelmeier. (2016) Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management. Advances in Therapy 34:2, pages 281-299.
Crossref
Crossref
Paul W. Jones, Nancy K. Leidy, Asha Hareendran, Rosa Lamarca, Ferran Chuecos & Esther Garcia Gil. (2016) The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies. Respiratory Research 17:1.
Crossref
Crossref
Ioanna Tsiligianni, Esther Metting, Thys van der Molen, Niels Chavannes & Janwillem Kocks. (2016) Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Juan José Soler-Cataluña, Jaume Sauleda, Luis Valdés, Pilar Marín, Ramón Agüero, Maite Pérez & Marc Miravitlles. (2016) Prevalencia y percepción de la variabilidad diaria de los síntomas en pacientes con enfermedad pulmonar obstructiva crónica estable en España. Archivos de Bronconeumología 52:6, pages 308-315.
Crossref
Crossref
Juan José Soler-Cataluña, Jaume Sauleda, Luis Valdés, Pilar Marín, Ramón Agüero, Maite Pérez & Marc Miravitlles. (2016) Prevalence and Perception of 24-h Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain. Archivos de Bronconeumología (English Edition) 52:6, pages 308-315.
Crossref
Crossref
Eric D. Bateman, Kenneth R. Chapman, Dave Singh, Anthony D. D’Urzo, Eduard Molins, Anne Leselbaum & Esther Garcia Gil. (2015) Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). Respiratory Research 16:1.
Crossref
Crossref
Adam P Garrow, Naimat Khan, Sarah Tyson, Jørgen Vestbo, Dave Singh & Janelle Yorke. (2015) The development and first validation of the Manchester Early Morning Symptoms Index (MEMSI) for patients with COPD. Thorax 70:8, pages 757-763.
Crossref
Crossref
Katharina Marth, Elisabeth Schuller & Wolfgang Pohl. (2015) Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD. Respiratory Medicine 109:5, pages 616-624.
Crossref
Crossref
Mario Cazzola, Kai M. Beeh, David Price & Nicolas Roche. (2015) Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD. Pulmonary Pharmacology & Therapeutics 31, pages 68-78.
Crossref
Crossref
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman. (2014) Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials. Clinical Investigation 4:12, pages 1095-1111.
Crossref
Crossref
Marc Miravitlles, Heinrich Worth, Juan José Soler Cataluña, David Price, Fernando De Benedetto, Nicolas Roche, Nina Skavlan Godtfredsen, Thys van der Molen, Claes-Göran Löfdahl, Laura Padullés & Anna Ribera. (2014) Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respiratory Research 15:1.
Crossref
Crossref